MS
AVNS

Murray Stahl’s Avanos Medical AVNS Stock Holding History

Murray Stahl’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-6,016
Closed -$203K – 387
2019
Q4 		$203K Sell
6,016
-72
-1% -$2.61K 0.01% 458
2019
Q3 		$228K Buy
6,088
+10
+0.2% +$381 0.01% 440
2019
Q2 		$265K Buy
6,078
+6
+0.1% +$257 0.01% 428
2019
Q1 		$259K Buy
+6,072
New +$272K 0.01% 434

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Murray Stahl's AVNS Position: Q1 2020 in Review

Murray Stahl sold out of Avanos Medical (AVNS) in Q1 2020, closing a stake of 6,016 shares — an estimated $203K sold.

Murray Stahl first reported a position in AVNS in Q1 2019 and held it in 4 quarters. The position peaked at $265K in Q2 2019. 272 funds tracked by Wall St. Rank hold AVNS as of Q1 2020.

  • Murray Stahl reported no remaining Avanos Medical position as of Q1 2020 after selling out during the quarter.
  • Murray Stahl sold 6,016 Avanos Medical shares in Q1 2020, an estimated $203K.
  • Murray Stahl first reported a position in Avanos Medical in Q1 2019 and held it in 4 quarters.
  • Murray Stahl's Avanos Medical position peaked at $265K in Q2 2019.
  • 272 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2020.

Based on Horizon Kinetics Asset Management's 13F filing for Q1 2020, filed 13 May 2020.